Literature DB >> 25794589

[Superficial bladder cancer: Transurethral resection and instillation therapy].

M Schenck1, G Lümmen.   

Abstract

Bladder cancer is the fifth most common tumor in men with the incidence of bladder tumors continuing to rise in industrialized and developed countries. Because 80% of all bladder tumors grow on the surface, endoscopic transurethral resection (TUR-B) can be used for complete removal. Due to continuous technical developments and improvements of endoscopic equipment, video imaging and bipolar resection (TUR-IS) offers a high level of safety. Despite optimal equipment, intra- and postoperative complications in transurethral electrosurgery of bladder tumors may occur.

Entities:  

Mesh:

Year:  2015        PMID: 25794589     DOI: 10.1007/s00120-015-3778-3

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  28 in total

Review 1.  Technique and complications of transurethral surgery for bladder tumours.

Authors:  Olivier Traxer; Federico Pasqui; Bernard Gattegno; Margaret S Pearle
Journal:  BJU Int       Date:  2004-09       Impact factor: 5.588

2.  Bilateral peroneal neuropathy after surgery in the lithotomy position.

Authors:  Ozlem Erol; Levent Ozçakar; Bayram Kaymak
Journal:  Aesthetic Plast Surg       Date:  2004 Jul-Aug       Impact factor: 2.326

3.  Fluid absorption during transurethral bladder surgery.

Authors:  J Ekengren; P Conner; M Lindholm; R G Hahn
Journal:  Scand J Urol Nephrol       Date:  1995-12

4.  Gender and body mass index as risk factors for bladder perforation during primary transurethral resection of bladder tumors.

Authors:  Kathleen Herkommer; Christian Hofer; Juergen E Gschwend; Martina Kron; Uwe Treiber
Journal:  J Urol       Date:  2012-03-14       Impact factor: 7.450

5.  Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. European Organization for Research and Treatment of Cancer Genitourinary Group.

Authors:  C Bouffioux; K H Kurth; A Bono; W Oosterlinck; C B Kruger; M De Pauw; R Sylvester
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

Review 6.  Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer.

Authors:  D L Lamm
Journal:  Clin Infect Dis       Date:  2000-09       Impact factor: 9.079

7.  A comparison between blind and nerve stimulation guided obturator nerve block in transurethral resection of bladder tumor.

Authors:  Mohammadhatef Khorrami; Mazaher Hadi; Amir Javid; Mohammad-Hossein Izadpahani; Mehrad Mohammadi Sichani; Mahtab Zargham; Farshid Alizadeh
Journal:  J Endourol       Date:  2012-10       Impact factor: 2.942

8.  Vesicorenal reflux and upper urinary tract transitional cell carcinoma after transurethral resection of recurrent superficial bladder carcinoma.

Authors:  J A De Torres Mateos; J M Banús Gassol; J Palou Redorta; J Morote Robles
Journal:  J Urol       Date:  1987-07       Impact factor: 7.450

9.  [Transurethral resection of bladder tumors and prostate enlargement in physiological saline solution (TURIS). A prospective study].

Authors:  A Rose; S Suttor; P J Goebell; R Rossi; H Rübben
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

10.  Over 500 obturator nerve blocks in the lithotomy position during transurethral resection of bladder tumor.

Authors:  Karolina Pladzyk; Lidia Jureczko; Tomasz Lazowski
Journal:  Cent European J Urol       Date:  2012-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.